These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 39102822)
1. Calciprotein particle counts associate with vascular remodelling in chronic kidney disease. Feenstra L; Reijrink M; Pasch A; Smith ER; Visser LM; Bulthuis M; Lodewijk ME; Mastik MF; Greuter MJW; Slart RHJA; Mulder DJ; Pol RA; Te Velde-Keyzer CA; ; Krenning G; Hillebrands JL Cardiovasc Res; 2024 Aug; ():. PubMed ID: 39102822 [TBL] [Abstract][Full Text] [Related]
2. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein). Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790 [TBL] [Abstract][Full Text] [Related]
3. Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease. Silaghi CN; Ilyés T; Van Ballegooijen AJ; Crăciun AM J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32365608 [TBL] [Abstract][Full Text] [Related]
4. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles. Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425 [TBL] [Abstract][Full Text] [Related]
5. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease. Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675 [TBL] [Abstract][Full Text] [Related]
6. Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease. Pruijm M; Lu Y; Megdiche F; Piskunowicz M; Milani B; Stuber M; Bachtler M; Vogt B; Burnier M; Pasch A J Hypertens; 2017 Oct; 35(10):2044-2052. PubMed ID: 28562422 [TBL] [Abstract][Full Text] [Related]
7. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review. Pluquet M; Kamel S; Choukroun G; Liabeuf S; Laville SM Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136575 [TBL] [Abstract][Full Text] [Related]
12. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop. Zeper LW; de Baaij JHF Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):368-374. PubMed ID: 31045659 [TBL] [Abstract][Full Text] [Related]
13. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate. Miura Y; Kurosu H; Kuro-O M Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998 [TBL] [Abstract][Full Text] [Related]
14. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. Bundy JD; Cai X; Scialla JJ; Dobre MA; Chen J; Hsu CY; Leonard MB; Go AS; Rao PS; Lash JP; Townsend RR; Feldman HI; de Boer IH; Block GA; Wolf M; Smith ER; Pasch A; Isakova T; Am J Kidney Dis; 2019 Jun; 73(6):806-814. PubMed ID: 30935773 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Smith ER; Ford ML; Tomlinson LA; Rajkumar C; McMahon LP; Holt SG Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144 [TBL] [Abstract][Full Text] [Related]
16. Regional distribution and severity of arterial calcification in patients with chronic kidney disease stages 1-5: a cross-sectional study of the Copenhagen chronic kidney disease cohort. Sørensen IMH; Saurbrey SAK; Hjortkjær HØ; Brainin P; Carlson N; Ballegaard ELF; Kamper AL; Christoffersen C; Feldt-Rasmussen B; Kofoed KF; Bro S BMC Nephrol; 2020 Dec; 21(1):534. PubMed ID: 33297991 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of abdominal aortic calcification in healthy living kidney donors. Leckstroem DC; Bhuvanakrishna T; McGrath A; Goldsmith DJ Int Urol Nephrol; 2014 Jan; 46(1):63-70. PubMed ID: 23783567 [TBL] [Abstract][Full Text] [Related]
19. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification. Ter Braake AD; Eelderink C; Zeper LW; Pasch A; Bakker SJL; de Borst MH; Hoenderop JGJ; de Baaij JHF Nephrol Dial Transplant; 2020 May; 35(5):765-773. PubMed ID: 31605492 [TBL] [Abstract][Full Text] [Related]
20. Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview. Izzo C; Secondulfo C; Bilancio G; Visco V; Virtuoso N; Migliarino S; Ciccarelli M; Di Pietro P; La Mura L; Damato A; Carrizzo A; Vecchione C Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]